Clinical feasibility of transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis: A prospective multicenter study in Japan.
dialysate-to-plasma ratio of creatinine (D/P Cr)
fluid overload
inadequate dialysis
residual renal function (RRF)
β2 microglobulin
Journal
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
ISSN: 1744-9987
Titre abrégé: Ther Apher Dial
Pays: Australia
ID NLM: 101181252
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
revised:
02
12
2021
received:
06
08
2021
accepted:
05
01
2022
pubmed:
10
1
2022
medline:
16
11
2022
entrez:
9
1
2022
Statut:
ppublish
Résumé
Although combined therapy with peritoneal dialysis (PD) and hemodialysis (HD) is widespread in Japan, its clinical utility has been reported only in retrospective or before-and-after test lacking a control group. We conducted a prospective, multicenter, observational cohort study of 176 incident PD patients and compared patient survival and changes in clinical parameters between patients on different dialysis modalities. During a median follow-up of 41 months, 47 patients transferred to combined therapy and 35 patients transferred directly to HD. Patients transferred to combined therapy had a significantly better survival than those transferred directly to HD. However, we could not establish this difference in a multivariate analysis because only six patients died among these groups. The decreases in urea nitrogen and serum creatinine were more prominent among patients directly transferred to HD. This is the first report revealing clinical feasibility of transfer to combined therapy for PD patients.
Identifiants
pubmed: 35000280
doi: 10.1111/1744-9987.13796
doi:
Types de publication
Observational Study
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1226-1234Subventions
Organisme : The Kidney Foundation
Informations de copyright
© 2022 International Society for Apheresis and Japanese Society for Apheresis.
Références
Chaudhary K, Sangha H, Khanna R. Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol. 2011;6(2):447-56.
Peritoneal Dialysis Adequacy Work G. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 2006;48(Suppl 1):S98-129.
Clinical practice recommendations for peritoneal dialysis adequacy. Am J Kidney Dis. 2006;48(Suppl 1):S130-58.
Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520-2.
Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis JSfDT, Japanese Society for Dialysis T. 2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis. Ther Apher Dial. 2010;14(6):489-504.
Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replace Therapy. 2020;6:41.
Maruyama Y, Yokoyama K, Nakayama M, Higuchi C, Sanaka T, Tanaka Y, et al. Combined therapy with peritoneal dialysis and hemodialysis: a multicenter retrospective observational cohort study in Japan. Blood Purif. 2014;38(2):149-53.
Matsuo N, Yokoyama K, Maruyama Y, Ueda Y, Yoshida H, Tanno Y, et al. Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. Clin Nephrol. 2010;74(3):209-16.
Kanda R, Io H, Nakata J, Makita Y, Sasaki Y, Matsumoto M, et al. Evaluation of long-term combination therapy with peritoneal dialysis and hemodialysis. Ther Apher Dial. 2017;21(2):180-4.
Kawanishi H, Hashimoto Y, Nakamoto H, Nakayama M, Tranaeus A. Combination therapy with peritoneal dialysis and hemodialysis. Perit Dial Int. 2006;26(2):150-4.
Moriishi M, Kawanishi H, Tsuchiya S. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function. Adv Perit Dial. 2010;26:67-70.
Murashima M, Hamano T, Abe M, Masakane I. Combination of once-weekly haemodialysis with peritoneal dialysis is associated with lower mortality compared with peritoneal dialysis alone: a longitudinal study. Clin Kidney J. 2021;14(6):1610-7.
Tanaka M, Ishibashi Y, Hamasaki Y, Kamijo Y, Idei M, Kawahara T, et al. Health-related quality of life on combination therapy with peritoneal dialysis and hemodialysis in comparison with hemodialysis and peritoneal dialysis: a cross-sectional study. Perit Dial Int. 2020;40(5):462-9.
Tanaka M, Ishibashi Y, Hamasaki Y, Kamijo Y, Idei M, Nishi T, et al. Bioimpedance spectroscopy-based fluid status in combined dialysis compared with hemodialysis and peritoneal dialysis: a cross-sectional study. Ther Apher Dial. 2020;24(4):373-9.
Maruyama Y. Does combined therapy with peritoneal dialysis and hemodialysis improve prognosis? Contrib Nephrol. 2018;196:64-70.
Yamashita AC. A kinetic model for peritoneal dialysis and its application for complementary dialysis therapy. Contrib Nephrol. 2012;177:3-12.
Waniewski J, Lindholm B. Fractional solute removal and KT/V in different modalities of renal replacement therapy. Blood Purif. 2004;22(4):367-76.
Chung MC, Yu TM, Wu MJ, Chuang YW, Muo CH, Chen CH, et al. Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan. BMC Nephrol. 2020;21(1):348.